Radiation dose reduction for CT-guided intrathecal nusinersen administration in adult patients with spinal muscular atrophy

被引:9
|
作者
Cordts, Isabell [1 ]
Deschauer, Marcus [1 ]
Lingor, Paul [1 ]
Burian, Egon [2 ]
Baum, Thomas [2 ]
Zimmer, Claus [2 ]
Maegerlein, Christian [2 ]
Sollmann, Nico [2 ,3 ]
机构
[1] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany
[2] Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Klinikum Rechts Isar, Munich, Germany
[3] Tech Univ Munich, TUM Neuroimaging Ctr, Klinikum Rechts Isar, Munich, Germany
关键词
LUMBAR PUNCTURE;
D O I
10.1038/s41598-020-60240-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intrathecal administration of nusinersen in adult spinal muscular atrophy (SMA) patients with scoliosis and spondylodesis requires image guidance, which is preferably achieved with multi-detector computed tomography (MDCT). As long-term treatment is necessary and patients are young, radiation doses should be reduced to a minimum whilst a sufficient image quality for precise interventional performance should be kept. We compared 44 MDCT standard-dose scans (133.0-200.0 mA) with a hybrid iterative reconstruction (iDose4) to 20 low-dose scans (20.0-67.0 mA) with iterative model reconstruction (IMR), which were performed for procedure planning of intrathecal nusinersen administration in 13 adult patients with SMA and complex spinal conditions. Qualitative image evaluation, including confidence for intervention planning, was performed by two neuroradiologists for standard- and low-dose scans. All 64 MDCT-guided intrathecal administrations of nusinersen were successful. The dose length product (DLP) was significantly lower when using low-dose scanning with IMR (median DLP of standard-dose scans: 92.0 mGy.cm vs. low-dose scans: 34.5 mGy.cm; p < 0.0001). Image quality was significantly reduced for low-dose compared to standard-dose scanning. However, bone/soft tissue contrast and confidence for intervention planning were not significantly impaired in low-dose MDCT according to both readers, showing good inter-reader agreement. Thus, we hereby demonstrate a low-dose MDCT protocol combined with advanced image reconstruction for scanning during procedure planning as a viable option for image guidance in intrathecal nusinersen treatment of adult SMA patients with complex spinal conditions.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy
    Mousa, Mohammad A.
    Aria, David J.
    Schaefer, Carrie M.
    Kaye, Robin D.
    Abruzzo, Todd A.
    Bernes, Saunder M.
    Willard, Scott D.
    Riemann, Monique C.
    Towbin, Richard B.
    PEDIATRIC RADIOLOGY, 2018, 48 (12) : 1797 - 1805
  • [32] A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy
    Mohammad A. Mousa
    David J. Aria
    Carrie M. Schaefer
    Robin D. Kaye
    Todd A. Abruzzo
    Saunder M. Bernes
    Scott D. Willard
    Monique C. Riemann
    Richard B. Towbin
    Pediatric Radiology, 2018, 48 : 1797 - 1805
  • [33] A Systematic Review of Procedural Complications from Transforaminal Lumbar Puncture for Intrathecal Nusinersen Administration in Patients with Spinal Muscular Atrophy
    Grayev, A.
    Schoepp, M.
    Kuner, A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2021, 42 (05) : 980 - 985
  • [34] Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1
    Pechmann, Astrid
    Langer, Thorsten
    Wider, Sabine
    Kirschner, Janbernd
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2018, 22 (01) : 122 - 127
  • [35] Feasibility analysis of intrathecal administration strategy of nusinersen based on Cobb angle in children with spinal muscular atrophy
    Huang, Jinjin
    Feng, Yijie
    Wang, Jia
    Huang, Siyi
    Jin, Jianing
    Xu, Lu
    Zhao, Congying
    Hua, Yi
    Li, Xiaoying
    Xu, Jingfang
    Li, Haibing
    Zhang, Huan
    Zhang, Yi
    Gao, Feng
    Mao, Shanshan
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 46 : 55 - 60
  • [36] Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen
    Andres-Benito, Pol
    Vazquez-Costa, Juan Francisco
    Garzon, Nancy Carolina Nungo
    Colomina, Maria J.
    Marco, Carla
    Gonzalez, Laura
    Terrafeta, Cristina
    Dominguez, Raul
    Ferrer, Isidro
    Povedano, Monica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [37] Impact of Nusinersen treatment on quality of life in adult patients with Spinal Muscular Atrophy
    Castanon, Felix Guerra
    Deardorff, Adam
    Zhao, Songzhu
    Severyn, Steven
    Kelly, Kristrina
    Tellez, Marco
    Heintzman, Sarah
    Sterling, Gary
    Kolb, Stephen
    Arnold, David
    Elsheikh, Bakri
    NEUROLOGY, 2023, 100 (17)
  • [38] Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen
    Silvia Bonanno
    Riccardo Zanin
    Luca Bello
    Irene Tramacere
    Virginia Bozzoni
    Luca Caumo
    Manfredi Ferraro
    Sara Bortolani
    Gianni Sorarù
    Mauro Silvestrini
    Veria Vacchiano
    Mara Turri
    Raffaella Tanel
    Rocco Liguori
    Michela Coccia
    Renato Emilio Mantegazza
    Tiziana Mongini
    Elena Pegoraro
    Lorenzo Maggi
    Journal of Neurology, 2022, 269 : 3264 - 3275
  • [39] Nusinersen treatment in adult patients with 5q spinal muscular atrophy
    Vazquez Costa, J.
    Monica, P.
    Nascimento, A.
    Kapetanovic, S.
    Moreno, A.
    Hervas, D.
    Pitarch, I.
    Nungo Garzon, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 832 - 832
  • [40] Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery
    Mendonca, Rodrigo de Holanda
    Fernandes, Hermann Dos Santos
    Schimmelpfeng Pinto, Rafael Barbero
    Matsui Junior, Ciro
    Polido, Graziela Jorge
    Serafim da Silva, Andre Macedo
    Grossklauss, Luis Fernando
    Reed, Umbertina Conti
    Zanoteli, Edmar
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (02) : 127 - 132